Initiation and Maintenance of Low‐Dose Transdermal Testosterone in Non‐Binary Individuals: A Retrospective Audit

20260 citationsJournal Articlehybrid Open Access

Authors

Peter Locke · Abbotsford Veterinary Clinic

Brendan J. Nolan · Abbotsford Veterinary Clinic

Abstract

Most non-binary individuals initiating low-dose transdermal testosterone continue doses lower than those recommended in current guidelines after 6-12 months of treatment. These hypothesis-generating findings highlight the need for studies evaluating the influence of low-dose testosterone on clinical outcomes and safety end-points.

Topics & Keywords

Hormonal and reproductive studies LGBTQ Health, Identity, and Policy Sexual function and dysfunction studies

UN Sustainable Development Goals

Gender equality

Publication Details

Published in: Clinical Endocrinology

DOI: 10.1111/cen.70110

Field-Weighted Citation Impact: 0.00